Lifeboat Foundation

Can We Immunize The World Against Future Pandemics? Dr Jonna Mazet, DVM, MPVM, PhD, UC Davis School of Veterinary Medicine — Global Virome Project.

Dr. Jonna Mazet, DVM, MPVM, PhD, is a Professor of Epidemiology and Disease Ecology at the UC Davis School of Veterinary Medicine, Founding Executive Director of the UC Davis One Health Institute, and Vice Provost For Grand Challenges At UC Davis.

Continue reading “Dr. Jonna Mazet, DVM, MPVM, PhD — One Health — Can We Immunize The World Against Future Pandemics?” »

The UK’s decision to delay second doses of coronavirus vaccines has received fresh support from research on the over-80s which found that giving the Pfizer/BioNTech booster after 12 weeks rather than three produced a much stronger antibody response.

A study led by the University of Birmingham in collaboration with Public Health England found that antibodies against the virus were three-and-a-half times higher in those who had the second shot after 12 weeks compared with those who had it after a three-week interval.

History tells us that games are an inseparable facet of humanity, and mainly for good reasons. Advocates of video games laud their pros: they help develop problem-solving skills, socialize, relieve stress, and exercise the mind and body—all at the same time! However, games also have a dark side: the potential for addiction. The explosive growth of the video game industry has spawned all sorts of games targeting different groups of people. This includes digital adaptations of popular board games like chess, but also extends to gambling-type games like online casinos and betting on horse races. While virtually all engaging forms of entertainment lend themselves to addictive behavior under specific circumstances, some video games are more commonly associated with addiction than others. But what exactly makes these games so potentially addictive?

This is a difficult question to answer because it deals directly with aspects of the human mind, and the inner workings of the mind are mostly a mystery. However, there may be a way to answer it by leveraging what we do know about the physical world and its laws. At the Japan Advanced Institute of Science and Technology (JAIST), Japan, Professor Hiroyuki Iida and colleagues have been pioneering a methodology called “motion in mind” that could help us understand what draws us towards games and makes us want to keep reaching for the console.

Their approach is centered around modeling the underlying mechanisms that operate in the mind when playing games through an analogy with actual physical models of motion. For example, the concepts of potential energy, forces, and momentum from classical mechanics are considered to be analogous to objective and/or subjective game-related aspects, including pacing of the game, randomness, and fairness. In their latest study published in IEEE Access, Professor Iida and Assistant Professor Mohd Nor Akmal Khalid, also from JAIST, linked their “motion in mind” model with the concepts of engagement and addiction in various types of games from the perceived experience of the player and their behaviors.

Fully vaccinated people don’t need to wear a mask or physically distance during outdoor or indoor activities, large or small, federal health officials said, the fullest easing of pandemic recommendations so far.

The fully vaccinated should continue to wear a mask while traveling by plane, bus or train, and the guidance doesn’t apply in certain places like hospitals, nursing homes and prisons, the U.S. Centers for Disease Control and Prevention said Thursday.

The agency said it was making the revisions based on the latest science indicating that being fully vaccinated cuts the risk of getting infected and spreading the virus to others, in addition to preventing severe disease and death.

A new study published by researchers from MIT and also from Immersion Health, Portland raises the alarm about possible unintended consequences of the mRNA vaccines currently being deployed against the COVID-19 disease.

The study findings were published in the peer reviewed journal: International Journal Of Vaccine Theory, Practice And Research. https://ijvtpr.com/index.php/IJVTPR/article/view/23/29.

A COVID-19 vaccine that could provide protection against existing and future strains of the COVID-19 coronavirus, and other coronaviruses, and costs about $1 a dose has shown promising results in early animal testing.

Vaccines created by UVA Health’s Steven L. Zeichner, MD, PhD, and Virginia Tech’s Xiang-Jin Meng, MD, PhD, prevented pigs from being becoming ill with a pig model coronavirus, porcine epidemic diarrhea virus (PEDV). The vaccine was developed using an innovative approach that Zeichner says might one day open the door to a universal vaccine for coronaviruses, including coronaviruses that previously threatened pandemics or perhaps even coronaviruses that cause some cases of the common cold.

Their coronavirus vaccine offers several advantages that could overcome major obstacles to global vaccination efforts. It would be easy to store and transport, even in remote areas of the world, and could be produced in mass quantities using existing vaccine-manufacturing factories.

Influenza, commonly known as the flu virus, places a substantial burden on public health in the United States. The U.S. Centers for Disease Control and Prevention (CDC) estimates that influenza has resulted in about 9 million to 45 million diseases, 140000 to 810000 hospitalizations, and 12000 to 61000 deaths each year over the past decade.

Though flu vaccines are readily available to the public, they need to be remodeled and administered every year to combat new viral variants, which can undermine vaccine efficacy. Because of this, scientists have aimed to develop a universal vaccine that can protect against all influenza strains, and that can last for many years.

Now, researchers at the National Institute of Allergy and Infectious Diseases (NIAID)’s Vaccine Research Center (VRC) and the University of Washington School of Medicine’s Institute for Protein Design (IPD) developed a universal flu vaccine candidate using small particles (nanoparticles), which can induce a long-lasting immune response.

This new species, Desulfovibrio diazotrophicus, is from a family of bacteria that survive and grow on sulfur-containing compounds. They are known as sulfate-reducing bacteria (SRB) and a biproduct of their activity is the release of the gas hydrogen sulfide, which has a characteristic ‘rotten egg’ smell. Whilst this is unpleasant for those around you, there is also some concern that it is detrimental for gut health; the presence of SRB has been associated with gut inflammation, inflammatory bowel disease (IBD) and colorectal cancer.

Despite this, evidence for a definitive link between SRB and chronic disease has never been established. For a start, they are very widespread; around half the human population have SRB in their gut, so maybe not all of them are bad? They may even have positive effects. They release energy and nutrients from the material that other bacteria produce when they are fermenting the food we eat.

This uncertainty triggered interest from the research community, including scientists from the Quadram Institute (QI), who want to understand exactly what SRB do in the microbiome and how they interact with food and the gut. Very few species have been characterized, most from Western countries. To broaden the picture, QI researchers have been working with Professor Chen Wei and colleagues from Jiangnan University, China to isolate and characterize SRB from the intestinal tract of healthy Chinese and British people. The research was funded by the Biotechnology and Biological Sciences Research Council, part of UKRI.

Implantable electronics are among the most promising healthcare technologies, as they can help to remotely monitor specific biological processes associated with a patient’s health. While researchers have developed a variety of implantable devices over the past decade or so, existing technologies have several limitations that can prevent their widespread use in clinical settings.

The first factor preventing the large-scale implementation of existing implantable technologies is the structural mismatch between these devices and most organs/tissues in the body, which typically have complex 1D or 3D structures. Secondly, reliably fixing soft electronic devices on organs that are moving or pulsating has so far proved to be highly challenging.

Researchers at Daegu-Gyeongbuk Institute of Science & Technology (DGIST) in South Korea and ETH Zürich have recently developed a new fiber-based strain-sensing device that could overcome the limitations of existing implantable electronics. This sensor, presented in a paper published in Nature Electronics, comprises a capacitive fiber strain sensor with an inductive coil for wireless readout.